Industry: Biotechnology Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
An innovative biotechnology company in France, focusing on microbial performance optimization and directed evolution research. The company is committed to providing high-performance strain solutions for industrial bio-manufacturing, agriculture and environment, helping partners to improve production efficiency, tolerance and product stability. Its core advantage lies in the combination of experimental automation, long-term culture and data screening, which can efficiently screen microorganisms with ideal characteristics under the conditions close to industrial environment, thus accelerating the transformation process from laboratory to industrialization. With this ability, the company has become an important promoter in the field of microbial engineering and sustainable biological innovation in Europe.
Introduction to core business:
1. Strain performance optimization service
Provide long-term adaptive screening and improvement of microorganisms to improve yield, tolerance or metabolic performance.
2. Customized microbial development
Design and optimize strain solutions according to customer objectives (such as specific metabolite production, environmental tolerance, substrate utilization, etc.).
3. Cooperative research and technology transformation
Cooperate with partners to carry out applied research and accelerate the landing from laboratory results to industrial production.
Main application fields:
1. Industrial biological manufacturing
Used to improve the yield and stability of fermentation products (such as enzymes, amino acids, organic acids, biofuels, etc.).
2. Agriculture and environment
Develop microorganisms with stronger stress tolerance for bio-fertilizer, soil improvement and pollution control.
Cooperation mode:
Seek partners who need microbial optimization and directional evolution solutions in agricultural environment, industrial biology and other fields.